Lannett Receives FDA Approvals For Two Products

Company Expects to Launch Temolozomide Capsules Shortly PHILADELPHIA, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA... Biopharmaceuticals, Generics, FDALannett Company, Temolozomide, Potassium Chloride
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news